Vallon Pharmaceuticals Announces Formation of Scientific Advisory Board
September 14, 2021 08:05 ET
|
Vallon Pharmaceuticals Inc.
- Inaugural appointments include globally renowned leaders and experts on attention-deficit/hyperactivity disorder (ADHD) and stimulant abuse PHILADELPHIA, PA, Sept. 14, 2021 (GLOBE NEWSWIRE)...
Cocrystal Pharma Provides Update on its COVID-19 Antiviral Discovery and Development Programs
May 03, 2021 08:00 ET
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., May 03, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel...
RespireRx Pharmaceuticals Inc. Provides Update on Its Development Programs
April 22, 2021 08:45 ET
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., April 22, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
QSAM Biosciences Appoints Charles J. Link, Jr., M.D., Experienced Biotech Executive and Innovator, to Board of Directors
February 16, 2021 09:00 ET
|
QSAM Biosciences Inc.
Austin, TX, Feb. 16, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation nuclear medicines for the treatment of cancer and related diseases, announced...